 | Up a level |
Journal Article
Hoeper, Marius M., Al-Hiti, Hikmet, Benza, Raymond L., Chang, Sung-A, Corris, Paul A., Gibbs, J. Simon R., Grunig, Ekkehard, Jansa, Pavel 
ORCID: 0000-0002-3711-7064, Klinger, James R., Langleben, David, McLaughlin, Vallerie V., Meyer, Gisela M. B., Ota-Arakaki, Jaquelina, Peacock, Andrew J., Pulido, Tomas, Rosenkranz, Stephan, Vizza, Carmine Dario ORCID: 0000-0002-3540-4983, Vonk-Noordegraaf, Anton, White, R. James, Chang, Mikyung, Kleinjung, Frank, Meier, Christian, Paraschin, Karen, Ghofrani, Hossein Ardeschir and Simonneau, Gerald
(2021).
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Lancet Resp. Med., 9 (6).
S. 573 - 585.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2213-2600
Simonneau, Gerald, Ghofrani, Hossein-Ardeschir, Corris, Paul A., Rosenkranz, Stephan, Gruenig, Ekkehard, White, Jim, McLaughlin, Vallerie V., Langleben, David, Meier, Christian, Busse, Dennis, Kleinjung, Frank and Benza, Raymond L. (2020). Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study. Pulm. Circ., 10 (4). THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 2045-8940